The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720 |
| |
Authors: | S SUZUKI X -K LI T SHINOMIYA S ENOSAWA H AMEMIYA M AMARI and S NAOE |
| |
Institution: | Department of Experimental Surgery and Bioengineering, National Children''s Medical Research Center, Tokyo, Japan;*EM Division and Pathology, Ohashi Hospital, Toho University School of Medicine, Tokyo, Japan |
| |
Abstract: | The in vitro treatment of lpr thymocytes with FTY720 resulted in a dose-dependent reduction in cell viability due to apoptosis. In order to study the effect of FTY720 in vivo, lpr mice received an oral daily dose of 1 mg/kg FTY720 for 14 days, beginning at 16 weeks of age which was when the animals were developing massive lymphoadenopathy. Compared with untreated lpr mice, FTY720-treated lpr mice had significantly prolonged lives. At 24 weeks of age, treated mice demonstrated markedly reduced weights of the spleen and lymph nodes, and the proportion of CD3+B220+ and CD4−CD8− cells in the thymus, spleen and lymph nodes decreased markedly. In addition, in these mice the percentage of CD4+CD8+ and CD3−B220− cells in the thymus and the percentage of CD4+CD8−, CD4−CD8+, CD3+B220− and CD3−B220+ cells in the spleen returned to almost the normal values observed in wild-type mice. Histological observation 1 day after the final administration of FTY720 revealed a remarkable infiltration of neutrophils in the lymphoid organs. Apoptotic cells were detected in all the lymphoid organs using in situDNA nick-end labelling. Electron microscopy showed that the apoptotic cells were ingested by phagocytes. FTY720 therapy is thus highly effective in Fas-mutant animals with abnormally expanding lymphocytes. |
| |
Keywords: | FTY720 apoptosis Isaria sinclairii immunosuppressant MRL-lpr/lpr mice |
|
|